# Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

> **NCT00851448** · NA · TERMINATED · sponsor: **Fresenius Kabi** · enrollment: 17 (actual)

## Conditions studied

- Cachexia
- Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** oral nutritional supplement, food for special medical purposes

## Key facts

- **NCT ID:** NCT00851448
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2011-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851448, "Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00851448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*